Lucy E Wilson

Plumb, I D., Mohr, N M., Hagen, M, Wiegand, R, Dumyati, G, Harland, K K., Krishnadasan, A, Gist, J J., Abedi, G, Fleming-Dutra, K E., Chea, N, Lee, J, Barter, D, Brackney, M, Fridkin, S F., Wilson, Lucy, Lovett, S A., Ocampo, V, Phipps, E C., Marcus, T M., Smithline, H A., Hou, P C., Lee, L C., Moran, G J., Krebs, E, Steele, M T., Lim, S C., Schrading, W A., Chinnock, B A., Beiser, D G., Faine, B, Haran, J P., Nandi, U, Chipman, A K., LoVecchio, F, Talan, D A., Pilishvili, T. (2023). Effectiveness of an mRNA vaccine booster dose against COVID-19 among U.S. healthcare personnel, October 2021–July 2022. ofad457. Open Forum Infectious Diseases.

Magill, S S., Sapiano, M RP., Ghkhale, R, Nadle, J, Johnston, H, Brousseau, G, Maloney, M, Ray, S M., Wilson, Lucy, Perlmutter, R, Lynfield, R, DeSilva, M, Sievers, M, Irizarry, L, Dumyati, G, Pierce, R, Zhang, A, Kainer, M, Fiore, A E., Dantes, R, Epstein, L. (2023). Epidemiology of Sepsis in U.S. Children and Young Adults Open Forum Infectious Diseases. 5. 10 Open Forum Infectious Diseases.

Stanton, R A., Campbell, D, McAllister, G A., Breaker, E, Adamczyk, M, Daniels, J B., Lutring, J D., Karlsson, M, Schutz, K, Jacob, J T., Wilson, Lucy E., Vaeth, E, Li, l, Lynfield, R, Snippes Vagnone, P M., Phipps, E C., Hancock, E B., Dumyati, G, Tsay, R, Cassidy, P M., Mounsey, J, Grass, J E., Bulens, S N., Walters, M S., Halpin, A L. (2023). Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile”, United States, 2012-17. 5. 76 Clinical Infectious Diseases.

Bulens, S N., Reses, H E., Ansari, U A., Grass, J E., Carmon, C, Albrecht, V, Lawsin, A, McAllister, G, Daniels, J, Lee, Y K., Yi, S, See, I, Jacob, J T., Bower, C W., Wilson, Lucy, Vaeth, E, Lynfield, R, Vagnone, P S., Shaw, K M., Dumyati, G, Tsay, R, Phipps, E C., Bamberg, W, Janelle, S J., Beldavs, Z G., Cassidy, P M., Kainer, M, Muleta, D, Mounsey, J T., Laufer-Halpin, A, Karlsson, M, Lutgring, J D., Walters, M S. (2023). Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.. 1. 51 70-77 American journal of infection control.

Stanton, R A., Campbell, D, McAllister, G A., Breaker, E, Adamczyk, M, Daniels, J B., Lutgring, J D., Karlsson, M, Schutz, K, Jacob, J T., Wilson, Lucy, Vaeth, E, Li, L, Lynfield, R, Snippes Vagnone, P M., Phipps, E C., Hancock, E B., Dumyati, G, Tsay, R, Cassidy, P M., Mounsey, J, Grass, J E., Bulens, S N., Walters, M S., Halpin, A L. (2022). Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.. 9. 66 e0049622 Antimicrobial agents and chemotherapy.

Guh, A Y., Yi, S H., Baggs, J, Winston, L, Parker, Eugene P., Johnston, H, Basiliere, E, Olson, D, Fridkin, S K., Mehta, N, Wilson, Lucy, Perlmutter, R, Holzbauer, S M., D'Heilly, P, Phipps, E C., Flores, K G., Dumyati, G K., Hatwar, T, Pierce, R, Wilson, C D., Watkins, J J., Korhonen, L, Paulick, A, Adamczyk, M, Gerding, D N., Reddy, S C. (2022). Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013.. 9. 9 ofac422 Open forum infectious diseases.

Chea, N, Eure, T, Penna, A R., Brown, C, Nadle, J, Godine, D, Frank, L, Czaja, C A., Johnston, H, Barter, D, Miller, B F., Angell, K, Marshall, K, Meek, J, Brackney, M, Carswell, S, Seidman, T, Wilson, Lucy, Perlmutter, R, Marceaux-Galli, K, Fell, A, Lim, S, Lynfield, R, Davis, S S., Phipps, E C., Sievers, M, Dumyati, G, Concannon, C, McCullough, K, Woods, A, Seshadri, S, Myers, C, Pierce, R, Guzman-Cottrill, J A., Escutia, G, Samper, M, Pena, S A., Adre, C, Groenewold, M, Thompson, N D., Magill, S S. (2022). Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020.. 8. 43 1058-1062 Infection control and hospital epidemiology.

Karlsson, M, Lutgring, J D., Ansari, U, Lawsin, A, Albrecht, V, McAllister, G, Daniels, J, Lonsway, D, McKay, L, Beldavs, Z, Bower, C, Dumyati, G, Gross, A, Jacob, J, Janelle, S, Kainer, M A., Lynfield, R, Phipps, E C., Schutz, K, Wilson, Lucy, Witwer, M L., Bulens, S N., Walters, M S., Duffy, N, Kallen, A J., Elkins, C A., Rasheed, J K. (2022). Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States.. 4. 28 389-397 Microbial drug resistance (Larchmont, N.Y.).

Jasani, G, Alemayehu, T, Chizmar, T, Wilson, Lucy. (2022). Changes in EMS utilization in the state of Maryland during the first 6 months of the COVID-19 pandemic.. 1. 17 41-48 American journal of disaster medicine.

Pilishvili, T, Gierke, R, Fleming-Dutra, K E., Farrar, J L., Mohr, N M., Talan, D A., Krishnadasan, A, Harland, K K., Smithline, H A., Hou, P C., Lee, L C., Lim, S C., Moran, G J., Krebs, E, Steele, M T., Beiser, D G., Faine, B, Haran, J P., Nandi, U, Schrading, W A., Chinnock, B, Henning, D J., Lovecchio, F, Lee, J, Barter, D, Brackney, M, Fridkin, S K., Marceaux-Galli, K, Lim, S, Phipps, E C., Dumyati, G, Pierce, R, Markus, T M., Anderson, D J., Debes, A K., Lin, M Y., Mayer, J, Kwon, J H., Safdar, N, Fischer, M, Singleton, R, Chea, N, Magill, S S., Verani, J R., Schrag, S J. (2021). Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.. 25. 385 e90 The New England journal of medicine.

Chea, N, Eure, T, Penna, A R., Brown, C J., Nadle, J, Godine, D, Frank, L, Czaja, C A., Johnston, H, Barter, D, Miller, B F., Angell, K, Marshall, K, Meek, J, Brackney, M, Carswell, S, Thomas, S, Wilson, Lucy, Perlmutter, R, Marceaux-Galli, K, Fell, A, Lim, S, Lynfield, R, Davis, S S., Phipps, E C., Sievers, M, Dumyati, G, Concannon, C, McCullough, K, Woods, A, Seshadri, S, Myers, C, Pierce, R, Guzman-Cottrill, J A., Escutia, G, Samper, M, Pena, S A., Adre, C, Groenewold, M, Thompson, N D., Magill, S S. (2021). Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020.. 1-5 Infection control and hospital epidemiology.

Pilishvili, T, Fleming-Dutra, K E., Farrar, J L., Gierke, R, Mohr, N M., Talan, D A., Krishnadasan, A, Harland, K K., Smithline, H A., Hou, P C., Lee, L C., Lim, S C., Moran, G J., Krebs, E, Steele, M, Beiser, D G., Faine, B, Haran, J P., Nandi, U, Schrading, W A., Chinnock, B, Henning, D J., LoVecchio, F, Nadle, J, Barter, D, Brackney, M, Britton, A, Marceaux-Galli, K, Lim, S, Phipps, E C., Dumyati, G, Pierce, R, Markus, T M., Anderson, D J., Debes, A K., Lin, M, Mayer, J, Babcock, H M., Safdar, N, Fischer, M, Singleton, R, Chea, N, Magill, S S., Verani, J, Schrag, S. (2021). Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.. 20. 70 753-758 MMWR. Morbidity and mortality weekly report.

Thompson, N D., Stone, N D., Brown, C J., Penna, A R., Eure, T R., Bamberg, W M., Barney, G R., Barter, D, Clogher, P, DeSilva, M B., Dumyati, G, Frank, L, Felsen, C B., Godine, D, Irizarry, L, Kainer, M A., Li, L, Lynfield, R, Mahoehney, J P., Maloney, M, Nadle, J, Pierce, R, Ray, S M., Davis, S S., Sievers, M, Srinivasan, K, Wilson, Lucy, Zhang, A Y., Magill, S S. (2021). Antimicrobial Use in a Cohort of US Nursing Homes, 2017.. 13. 325 1286-1295 JAMA.

Magill, S S., O'Leary, E, Ray, S M., Kainer, M A., Evans, C, Bamberg, W M., Johnston, H, Janelle, S J., Oyewumi, T, Lynfield, R, Rainbow, J, Warnke, L, Nadle, J, Thompson, D L., Sharmin, S, Pierce, R, Zhang, A Y., Ocampo, V, Maloney, M, Greissman, S, Wilson, Lucy, Dumyati, G, Edwards, J R., Chea, N, Neuhauser, M M. (2021). Assessment of the Appropriateness of Antimicrobial Use in US Hospitals.. 3. 4 e212007 JAMA network open.

Blanco, N, Robinson, G L., Heil, E L., Perlmutter, R, Wilson, Lucy, Brown, C H., Heavner, M S., Nadimpalli, G, Lemkin, D, Morgan, D J., Leekha, S. (2021). Impact of a C. difficile infection (CDI) reduction bundle and its components on CDI diagnosis and prevention.. 3. 49 319-326 American journal of infection control.

Band, V I., Satola, S W., Smith, R D., Hufnagel, D A., Bower, C, Conley, A B., Rishishwar, L, Dale, S E., Hardy, D J., Vargas, R L., Dumyati, G, Kainer, M A., Phipps, E C., Pierce, R, Wilson, Lucy, Sorensen, M, Nilsson, E, Jordan, I K., Burd, E M., Farley, M M., Jacob, J T., Ernst, R K., Weiss, D S. (2021). Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant <i>Enterobacterales</i> in the United States.. 1. 12 mBio.

Irvin, R, Ntiri-Reid, B, Kleinman, M, Agee, T, Hitt, J, Anaedozie, O, Arowolo, T, Cassidy-Stewart, H, Bush, C, Wilson, Lucy, Millman, A J., Nelson, N P., Canary, L, Brinkley, S, Moon, J, Falade-Nwulia, O, Sulkowski, M S., Thomas, D L., Melia, M T. (2020). Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in Maryland.. 12. 27 1388-1395 Journal of viral hepatitis.

Fay, K, Gokhale, R, Dantes, R, Thompson, N, Katz, D E., Ray, S M., Wilson, Lucy, Perlmutter, R, Nadle, J, Godine, D, Frank, L, Brousseau, G, Johnston, H, Bamberg, W, Dumyati, G, Nelson, D, Lynfield, R, DeSilva, M, Kainer, M, Zhang, A, Ocampo, V, Samper, M, Pierce, R, Irizarry, L, Sievers, M, Maloney, M, Fiore, A, Magill, S S., Epstein, L. (2020). Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock.. 7. 3 e206004 JAMA network open.

Magill, S S., O'Leary, E, Ray, S M., Kainer, M A., Evans, C, Bamberg, W M., Johnston, H, Janelle, S J., Oyewumi, T, Lynfield, R, Rainbow, J, Warnke, L, Nadle, J, Thompson, D L., Sharmin, S, Pierce, R, Zhang, A Y., Ocampo, V, Maloney, M, Greissman, S, Wilson, Lucy, Dumyati, G, Edwards, J R. (2020). Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penna, A R., Sancken, C L., Stone, N D., Eure, T R., Bamberg, W, Barney, G, Barter, D, Carswell, S, Clogher, P, Dumyati, G, Felsen, C B., Frank, L, Godine, D, Johnston, H, Kainer, M A., Li, L, Lynfield, R, Mahoehney, J P., Nadle, J, Pierce, R, Ray, S M., Davis, S S., Sievers, M, Wilson, Lucy, Zhang, A Y., Magill, S S., Thompson, N D. (2020). Documentation of acute change in mental status in nursing homes highlights opportunity to augment infection surveillance criteria.. 1-3 Infection control and hospital epidemiology.

Tewarson, Hemi, Greene, Katie, Williamson, Kirk, Fraser, Mike, Plescia, Marcus, Lane, J.T., Sharfstein, Josh, Wilson, Lucy. (2020). Roadmap to Recovery: A Public Health Guide for Governors.

Wilson, Lucy. (2020). How to Avoid Infection After a COVID-19 Death - an Ebola Response veteran explains. The Conversation.

Guh, A Y., Mu, Y, Winston, L G., Johnston, H, Olson, D, Farley, M M., Wilson, Lucy, Holzbauer, S M., Phipps, E C., Dumyati, G K., Beldavs, Z G., Kainer, M A., Karlsson, M, Gerding, D N., McDonald, L C. (2020). Trends in U.S. Burden of <i>Clostridioides difficile</i> Infection and Outcomes.. 14. 382 1320-1330 The New England journal of medicine.

Novosad, S A., Mu, Y, Winston, L G., Johnston, H, Basiliere, E, Olson, D M., Farley, M M., Revis, A, Wilson, Lucy, Perlmutter, R, Holzbauer, S M., Whitten, T, Phipps, E C., Dumyati, G K., Beldavs, Z G., Davis, C M., Kainer, M, Gerding, D N., Guh, A Y. (2020). Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.. 2. 35 412-419 Journal of general internal medicine.

Thompson, N D., Penna, A, Eure, T R., Bamberg, W M., Barney, G, Barter, D, Clogher, P, DeSilva, M B., Dumyati, G, Epson, E, Frank, L, Godine, D, Irizarry, L, Kainer, M A., Li, L, Lynfield, R, Mahoehney, J P., Nadle, J, Ocampo, V, Perry, L, Ray, S M., Davis, S S., Sievers, M, Wilson, Lucy, Zhang, A Y., Stone, N D., Magill, S S. (2020). Epidemiology of Antibiotic Use for Urinary Tract Infection in Nursing Home Residents.. 1. 21 91-96 Journal of the American Medical Directors Association.

Guh, A Y., Hatfield, K M., Winston, L G., Martin, B, Johnston, H, Brousseau, G, Farley, M M., Wilson, Lucy, Perlmutter, R, Phipps, E C., Dumyati, G K., Nelson, D, Hatwar, T, Kainer, M A., Paulick, A L., Karlsson, M, Gerding, D N., McDonald, L C. (2019). Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.. 10. 69 1667-1674 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Weng, M K., Brooks, R B., Glowicz, J, Keckler, M S., Christensen, B E., Tsai, V, Mitchell, C S., Wilson, Lucy, Laxton, R, Moulton-Meissner, H, Fagan, R. (2019). Outbreak investigation of Pseudomonas aeruginosa infections in a neonatal intensive care unit.. 9. 47 1148-1150 American journal of infection control.

Weng, M K., Adkins, S H., Bamberg, W, Farley, M M., Espinosa, C C., Wilson, Lucy, Perlmutter, R, Holzbauer, S, Whitten, T, Phipps, E C., Hancock, E B., Dumyati, G, Nelson, D S., Beldavs, Z G., Ocampo, V, Davis, C M., Rue, B, Korhonen, L, McDonald, L C., Guh, A Y. (2019). Risk factors for community-associated Clostridioides difficile infection in young children.. 147 e172 Epidemiology and infection.

Magill, S S., O'Leary, E, Janelle, S J., Thompson, D L., Dumyati, G, Nadle, J, Wilson, L E., Kainer, M, Lynfield, R, Greissman, S, Ray, S M., Beldavs, Z, Gross, C, Bamberg, W, Sievers, M, Concannon, C, Buhr, N, Warnke, L, Maloney, M, Ocampo, V, Brooks, J, Oyewumi, T, Sharmin, S, Richards, K, Rainbow, J, Samper, M, Hancock, E B., Leaptrot, D, Scalise, E, Badrun, F, Phelps, R, Edwards, J R. (2018). Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. 18. 379 1732-1744 New England Journal of Medicine.

Blanco, N, O'Hara, L M., Robinson, G L., Brown, J, Heil, E, Brown, C H., Stump, B D., Sigler, B W., Belani, A, Miller, H L., Chiplinski, A, Perlmutter, R, Wilson, L E., Morgan, D J., Leekha, S. (2018). Health care worker perceptions toward computerized clinical decision support tools for Clostridium difficile infection reduction: A qualitative study at 2 hospitals. 10. 46 1160-1166 American Journal of Infection Control.

Guh, A Y., Mu, Y, Baggs, J, Winston, L G., Bamberg, W, Lyons, C, Holzbauer, S M., Wilson, L E., Farley, M M., Phipps, E C., Beldavs, Z G., Kainer, M A., Karlsson, M, Gerding, D N., Dumyati, G. (2018). Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.. 7. 46 840-842 American Journal of Infection Control.

Bulens, S N., Yi, S H., Walters, M S., Jacob, J T., Bower, C, Reno, J, Wilson, L, Vaeth, E, Bamberg, W, Janelle, S J., Lynfield, R, Vagnone, P S., Shaw, K, Kainer, M, Muleta, D, Mounsey, J, Dumyati, G, Concannon, C, Beldavs, Z, Cassidy, P M., Phipps, E C., Kenslow, N, Hancock, E B., Kallen, A J. (2018). Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. 4. 24 727-734 Emerging Infectious Diseases.

Akinboyo, I C., Sick-Samuels, A C., Singeltary, E, Fackler, J, Ascenzi, J, Carroll, K C., Maldonado, Y, Brooks, R B., Benowitz, I, Wilson, L E., Lipuma, J J., Milstone, A M. (2018). Multistate Outbreak of an Emerging Burkholderia cepacia Complex Strain Associated With Contaminated Oral Liquid Docusate Sodium. 2. 39 237-239 Infection Control and Hospital Epidemiology.

Guh, A Y., Adkins, S H., Li, Q, Bulens, S N., Farley, M M., Smith, Z, Holzbauer, S M., Whitten, T, Phipps, E C., Hancock, E B., Dumyati, G, Concannon, C, Kainer, M A., Rue, B, Lyons, C, Olson, D M., Wilson, Lucy, Perlmutter, R, Winston, L G., Parker, E, Bamberg, W, Beldavs, Z G., Ocampo, V, Karlsson, M, Gerding, D N., McDonald, L C. (2017). Risk Factors for Community-Associated <i>Clostridium difficile</i> Infection in Adults: A Case-Control Study.. 4. 4 ofx171 Open forum infectious diseases.

Guh, A Y., Adkins, S H., Li, Q, Bulens, S N., Farley, M M., Smith, Z, Holzbauer, S M., Whitten, T, Phipps, E C., Hancock, E B., Dumyati, G, Concannon, C, Kainer, M A., Rue, B, Lyons, C, Olson, D M., Wilson, L, Perlmutter, R, Winston, L G., Parker, E, Bamberg, W, Beldavs, A G., Ocampo, V, Karlsson, M, Gerding, D N., McDonald, L C. (2017). Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study. 4. 4 Open Forum in Infectious Diseases.

Doll, M, Preas, M A., Johnson, J, Mitchell, C, Roup, B, Wilson, L, Carothers, C, Nkonge, G, Leekha, S. (2017). A Pseudo-outbreak of Aspergillosis at a Tertiary Care Hospital: Thinking Beyond the Infection Control Risk Assessment. 1. 38 115-118 Infection Control and Hospital Epidemiology.

Wilson, L E. (2017). National Academies of Sciences, Engineering, Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C, Phase Two Report. National Academies of Sciences, Engineering, Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C, Phase Two Report Washington, DC: The National Academies Press.

Wilson, L E., et al, Lucy. (2016). National Academies of Sciences, Engineering, Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States, Phase One Report. National Academies of Sciences, Engineering, Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States, Phase One Report Washington, DC: The National Academies Press.

Guh, A Y., Bulens, S N., Mu, Y, Jacob, J T., Reno, J, Scott, J, Wilson, L E., Vaeth, E, Lynfield, R, Shaw, K, Vagnone, P S., Bamberg, W M., Janelle, S J., Dumyati, G, Concannon, C, Beldavs, Z, Cunningham, M, Cassidy, M, Phipps, E, Kenslow, N, Travis, T, Lonsway, D, Rasheed, J K., Limbago, B M., Kallen, A J. (2015). Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. 14. 314 1479-87 Journal of the American Medical Association.

Chea, N, Bulens, S N., Kongphet-Tran, T, Lynfield, R, Shaw, K M., Vagnone, P S., Kainer, M A., Muleta, D B., Wilson, L, Vaeth, E, Dumyati, G, Concannon, C, Phipps, E C., Culbreath, K, Janelle, S J., Bamberg, W M., Guh, A Y., Limbago, B, Kallen, A J. (2015). Improved Phenotype-based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae. 9. 21 1611-1616 Emerging Infectious Diseases.

Dantes, R, Mu, Y, Hicks, L A., Cohen, J, Bamberg, W, Beldavs, Z G., Dumyati, G, Farley, M M., Holzbauer, S, Meek, J, Phipps, E, Wilson, L, Winston, L G., McDonald, C, Lessa, F C. (2015). Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. 3. 2 (Summer) Open Forum for Infectious Diseases.

Lessa, F C., Mu, Y, Bamberg, W M., Beldavs, Z G., Dumyati, G K., Dunn, J R., Farley, M M., Holzbauer, S M., Meek, J I., Phipps, E C., Wilson, L E., Winston, L G., Cohen, J A., Limbago, B M., Fridkin, S K., Gerding, D N., McDonald, L C. (2015). Burden of Clostridium difficile infection in the United States. 9. 372 825-834 New England Journal of Medicine.

Nelson, G, Fermo, O, Thakur, K, Felton, E, Bang, J, Wilson, L, Rhee, S, Llinas, R, Johnson, K, Sullivan, D. (2014). Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report. 1. 7 327 BMC Research Notes.

Beaudoin, A L., Torso, L, Richards, K, Said, M, Longenberger, A, Van Beneden, C, Ostroff, S, Wendt, J, Dooling, K, Wise, M, Blythe, D, Wilson, L, Moll, M, Perz, J F. (2014). Invasive group A Streptococcus infections associated with liposuction surgery at outpatient facilities not subject to state or federal regulation. 7. 174 1136-42 JAMA Internal Medicine.

Johnson, J K., Wilson, L E., Zhao, L, Richards, K, Thom, K, Harris, A D. (2014). Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland. Special topic Issue: Carbapenem-Resistant Enterobacteriaceae and Multidrug-Resistant Organisms 4. 35 443-5 Infection Control and Hospital Epidemiology.

Magill, S S., Edwards, J R., Bamberg, W, Beldavs, Z G., Dumyati, G, Kainer, M A., Lynfield, R, Maloney, M, McAllister-Hollod, L, Nadle, J, Ray, S M., Thompson, D L., Wilson, L, Fridkin, S K. (2014). Multistate point-prevalence survey of health care-associated infections. 13. 370 1198-208 New England Journal of Medicine.

Wendt, J M., Cohen, J A., Mu, Y, Dumyati, G K., Dunn, J R., Holzbauer, S M., Winston, L G., Johnston, H L., Meek, J I., Farley, M M., Wilson, L E., Phipps, E C., Beldavs, Z G., Gerding, D N., McDonald, L C., Gould, C V., Lessa, F C. (2014). Clostridium difficile infection among children across diverse US geographic locations. 4. 133 651-8 Pediatrics.

Said, M A., Haile, C, Palabindala, V, Barker, N, Myers, R, Thompson, R, Wilson, L, Allan-Martinez, F, Montgomery, J, Monroe, B, Tack, D, Reynolds, M, Damon, I, Blythe, D. (2013). Transmission of vaccinia virus, possibly through sexual contact, to a woman at high risk for adverse complications. 12. 178 e1375-8 Military Medicine.

Chitnis, A S., Holzbauer, S M., Belflower, R M., Winston, L G., Bamberg, W M., Lyons, C, Farley, M M., Dumyati, G K., Wilson, L E., Beldavs, Z G., Dunn, J R., Gould, L H., MacCannell, D R., Gerding, D N., McDonald, L C., Lessa, F C. (2013). Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. 14. 173 1359-67 JAMA Internal Medicine.

Savard, Patrice, Carroll, Karen, Wilson, L E., Perl, Trish. (2013). The challenges of carbapenemase-producing enterobacteriaceae and infection prevention: protecting patients in the chaos. 7. 34 730-9. https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology: Infect Control Hosp Epidemiol.

Rao, A K., Luckman, E, Wise, M E., MacCannell, T, Blythe, D, Lin, Y, Xia, G, Drobeniuc, J, Noble-Wang, J, Arduino, M J., Thompson, N D., Patel, P R., Wilson, L E. (2013). Outbreak of hepatitis C virus infections at an outpatient hemodialysis facility: the importance of infection control competencies. 2. 40 101-10 Nephrology Nursing.

Wilson, L E., Webster, Renee, O'Conner, Patricia. (2013). Public Health Vulnerability Review: Drug Diversion, Infection Risk, and David Kwiatkowski's Employment as a Healthcare Worker in Maryland. Baltimore, MD:

Gopinath, R, Savard, P, Carroll, K C., Wilson, L E., Landrum, B M., Perl, T M. (2013). Infection prevention considerations related to New Delhi metallo-β-lactamase Enterobacteriaceae: a case report. 1. 34 99-100 Infection Control and Hospital Epidemiology.

Wilson, L E., Blythe, D, Sharfstein, J M. (2012). Fungal meningitis from injection of contaminated steroids: a compounding problem. 23. 308 2461-2 JAMA.

Thom, K A., Maragakis, L L., Richards, K, Johnson, J K., Roup, B, Lawson, P, Harris, A D., Fuss, E P., Pass, M A., Blythe, D, Perencevich, E N., Wilson, L E. (2012). Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. 9. 33 883-8 Infection Control and Hospital Epidemiology.

Savard, P, Gopinath, R, Zhu, W, Kitchel, B, Rasheed, J K., Tekle, T, Roberts, A, Ross, T, Razeq, J, Landrum, M, Wilson, L E., Limbago, B, Perl, T, Carroll, K. (2011). First NDM-positive Salmonella sp. strain identified in the United States. 12. 55 5957-8 Antimicrobial Agents and Chemotherapy.

Yehia, B R., Fleishman, J A., Wilson, L, Hicks, P L., Gborkoquellie, T T., Gebo, K A. (2011). Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy. 9. 12 535-43 HIV Medicine.

Wilson, L E., Korthuis, T, Fleishman, J A., Conviser, R, Lawrence, P B., Moore, R D., Gebo, K A. (2011). HIV-related medical service use by rural/urban residents: a multistate perspective. 8. 23 971-979 AIDS Care.

Wilson, L E., Gallant, J E. (2009). HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations. 2. 48 214-221 Clinical Infectious Diseases.

Greenbaum, A H., Wilson, L E., Keruly, J C., Moore, R D., Gebo, K A. (2008). Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals. 17. 22 2331-9 AIDS.

Burkey, M D., Wilson, L E., Moore, R D., Lucas, G M., Francis, J, Gebo, K A. (2008). The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.. 10. 9 858-62 HIV Medicine.

Gebo, K A., Burkey, M D., Lucas, G M., Moore, R D., Wilson, L E. (2006). Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. 4. 43 426-32 Journal of AIDS.

Wilson, L E., Torbenson, M, Astemborski, J, Faruki, H, Spoler, C, Rai, R, Mehta, S, Kirk, G D., Nelson, K, Afdahl, N, Thomas, D L. (2006). Progression of liver fibrosis among injection drug users with chronic hepatitis C. 4. 43 788-95 Hepatology.

Wilson, L E., Thomas, D L., Astemborski, J, Freedman, T L., Vlahov, D. (2002). Prospective study of infective endocarditis among injection drug users. 12. 185 1761-66 Journal of Infectious Diseases.

Rai, R M., Wilson, L E., Astemborski, J, Anania, F A., Torbenson, M, Vlahov, D, Strathdee, S, Spoler, C P., Boitnott, J K., Thomas, D L. (2002). Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. 5. 35 1247-55 Hepatology.

Wilson, L E., Umemura, T, Astemborski, J, Ray, S C., Alter, H J., Strathdee, S A., Vlahov, D, Thomas, D L. (2001). Dynamics of SEN virus infection among injection drug users. 10. 184 1315-19 Journal of Infectious Diseases.

Safaeian, M, Wilson, L E., Taylor, E, Thomas, D L., Vlahov, D. (2000). HTLV-II and bacterial infections among injection drug users. 5. 24 483-7 Journal of AIDS.

Thomas, D L., Astemborski, J, Rai, R, Anania, F, Schaeffer, M, Galai, N, Nolt, K, Nelson, K E., Strathdee, S A., Johnson, L, Laeyendecker, O, Boitnott, J, Wilson, L E., Vlahov, D. (2000). The natural history of hepatitis C virus infection: host, viral, and environmental factors. 4. 284 450-6 JAMA.

Wilson, L E., Barry, Michele. (2000). Chapter 165: Viral Hemorrhagic Fevers. Current Therapy of Infectious Disease, 2nd Edition Second. Chapter 165 St Louis, MI: Mosby, Inc.

Blumenthal, P D., Wilson, L E., Remsburg, R E., Huggins, G R. (1994). Contraceptive outcomes among post-partum and post-abortal adolescents. 5. 50 451-60 Contraception.

Snow, R C., Wilson, L E. (1994). Chapter 1: Why Pharmacokinetics? An Introduction and Overview. Steroid Contraceptives and Women's Response: Regional Variability in Side-Effects and Steroid Pharmacokinetics First Edition. 1-7 New York, NY: Plenum Press.

Hohmann, C F., Wilson, L, Coyle, J T. (1991). Efferent and afferent connections of mouse sensory-motor cortex following cholinergic deafferentation at birth. 2. 1 158-72 Cerebral Cortex.

Wilson, Lucy. Workshop Report: Preparing for the Next Pandemic.

Wilson, Lucy, Han, Fei, Dezman, Zac, Henderson, Morgan, Stockwell, Ian. Reducing Patient Risk of COVID-19 Hospitalization through Actionable Artificial Intelligence. to be determined.

Taherzadeh, Sanaz, Wilson, Lucy E., Alemayehu, Teferra, Chizmar, Timothy. The Impact of COVID-19 on Pre-hospital Cardiac and Respiratory Issues in Maryland: A Comparison of Cardiopulmonary Resuscitation and Intubation Pre- and Post-COVID-19 Onset.

Chea, Nora, Wilson, Lucy. Characteristics of healthcare personnel who reported concerns related to PPE use during care of COVID-19 patients. Antimicrobial Stewardship & Healthcare Epidemiology.